Syra Health Corp.
SYRA
$0.17
$0.0431.54%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 76.16% | 70.21% | 65.18% | 22.64% | -27.94% |
| Total Depreciation and Amortization | -67.36% | -136.45% | -60.10% | -0.49% | -63.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -54.15% | 808.98% | 445.35% | 382.81% | 350.23% |
| Change in Net Operating Assets | -39.88% | 289.83% | 286.11% | 1,915.16% | 456.70% |
| Cash from Operations | 84.73% | 91.66% | 87.76% | 43.86% | -6.27% |
| Capital Expenditure | 99.10% | 100.00% | 100.00% | 50.89% | 27.45% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 99.10% | 100.00% | 100.00% | 50.89% | 27.45% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 15.32% | 70.42% | 78.91% | 75.82% | 82.39% |
| Issuance of Common Stock | -99.40% | -99.81% | -73.57% | -73.57% | -53.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -116.17% | -104.85% | -79.10% | -80.04% | -65.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 11.76% | -126.91% | -54.33% | -128.29% | -127.00% |